us$50 million worth for biota ???

Hi everyone,

Its getting better every day.

The following article speculates that the $1 billion worth on antivirals will be equally split between Tamiflu and Relenza....

If this is true we are looking at approx US$50 million for Biota.

jojo

Gilead developed the anti-viral drug Tamiflu, which was singled out for mention in Bush's announcement, along with Relenza, made by GlaxoSmithKline of England. Under a licensing deal, Tamiflu is manufactured by Roche while Gilead receives royalties, typically 10 percent. Assuming the $1.029 billion Bush has allocated for anti-viral drugs is split evenly among Tamiflu and Relenza, Gilead's share would likely be about $50 million.

http://www.mercurynews.com/mld/mercurynews/news/13058940.htm